Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder (PERFORM) study has been initiated to better understand the course of a depressive episode and its impact on patient functioning. This analysis aimed to identify sociodemographic and clinical factors associated with failure to achieve remission at month 2 after initiating or switching antidepressant monotherapy and with subsequent relapse at month 6 for patients in remission at month 2. MATERIALS AND METHODS: <0.05). RESULTS: (OR 0.51), depressive episode >8 weeks (OR 0.51), being in psychotherapy (OR 0.51), sexual dysfunction (OR 0.62), and severity of depression (OR 0.87). Factors significantly associated with relapse at month 6 were male sex (OR 2.47), being married or living as a couple (OR 2.73), residual patient-reported cognitive symptoms at 2 months (OR 1.12 per additional unit of Perceived Deficit Questionnaire-5 score) and residual depressive symptoms at 2 months (OR 1.27 per additional unit of Patient Health Questionnaire-9 score). CONCLUSION: Different factors appear to be associated with failure to achieve remission in patients with major depressive disorder and with subsequent relapse in patients who do achieve remission. Patient-reported cognitive dysfunction is an easily measurable and treatable characteristic that may be associated with an increased likelihood of relapse at 6 months in patients who have achieved remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MDD patients recover slowly due to residual cognitive symptoms during remission; thus, remission may not be achieved after multiple interventions.4”
From A Randomized Controlled Study of Efficacy and Cognitive Function Improvement of Vortioxetine and Escitalopram in Patients with Depression in Chinese Han Nationality (2024) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
(1976) · Medical Entomology and Zoology · Cited by 8,899
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Self-citationRush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 3×
“The role of sex as a factor associated with relapse in MDD remains uncertain, with previous studies yielding conflicting data.(21,22,27,64) The relationship between marital status and depression is also complex; however, previous studies have shown low relationship satisfaction to be a risk factor for depression, whic…”
The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
Manea, L., Gilbody, S., & McMillan, D. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110829 · Cited by 1,966
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“For patients in remission at 2 months, relapse at the 6-month visit was defined as: (i) treatment modification (switch or combination) for lack of efficacy at the 6-month visit;(47) or (ii) PHQ-9 total score 10 at the 6-month visit,(32) or MADRS total score 22 at the 6-month visit if PHQ-9 was missing,(48) or CGI-S…”
Rush, A. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.11.1905 · Cited by 870
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
Residual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791 · cited 8×
“In this study, the remission rate at month 2 was 29.7%; this is lower than typically reported in clinical trial settings, but is in line with the remission rate reported in more naturalistic studies, such as STAR*D. 13 The relatively low remission rate highlights the fact that achieving remission is still a major unme…”
InfluentialThe STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Kessler, R. C., Birnbaum, H. G., Shahly, V., Bromet, E., Hwang, I., McLaughlin, K. A., Sampson, N., Andrade, L. H., de Girolamo, G., Demyttenaere, K., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20634 · Cited by 477
Self-citationNierenberg, A. A., Husain, M. M., Trivedi, M. H., Fava, M., Warden, D., Wisniewski, S. R., Miyahara, S., & Rush, A. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709006011 · Cited by 458
Judd, L. L., Paulus, M. J., Schettler, P. J., Akiskal, H. S., Endicott, J., Leon, A. C., Maser, J. D., Mueller, T., Solomon, D. A., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1501 · Cited by 458
Marital distress and DSM-IV psychiatric disorders in a population-based national survey.
Whisman, M. A. (2007) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.116.3.638 · Cited by 451
Lam, R. W., Kennedy, S. H., McIntyre, R. S., & Khullar, A. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405901206 · Cited by 438
McKnight, P. E., & Kashdan, T. B. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.005 · Cited by 400 · cited 1×
“equal or exceed those associated with other severe chronic medical conditions, such as diabetes and congestive heart failure.(4) Multiple domains of functioning may be impaired;(4) consequently, MDD can have a significant impact on both quality of life and work productivity.”
Defining remission by cut off score on the MADRS: selecting the optimal value
Hawley, C. J., Gale, T. M., & Sivakumaran, T. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00451-7 · Cited by 266
Whisman, M. A., & Uebelacker, L. A. (2009) · Psychology and Aging · doi:10.1037/a0014759 · Cited by 260 · cited 1×
“21,22,27,64 74 With regard to the association of higher PHQ-9 total score with increased likelihood of relapse, it is well documented that residual depressive symptoms after remission are associated with an increased risk of subsequent relapse in patients with MDD. 29,66,75 It is not known how…”
Spijker, J., Bijl, R. V., De Graaf, R., & Nolen, W. A. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.103002122.x · Cited by 254
Defining successful treatment outcome in depression using the PHQ-9: A comparison of methods
McMillan, D., Gilbody, S., & Richards, D. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.030 · Cited by 247 · cited 1×
“However, this is based on the theoretical absence of depressive symptoms at this score, rather than an accepted definition of remission.(32,85) Validation studies of the PHQ-9 scale established a score of 10 or higher as the cutoff for a diagnosis of depression.”
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.007 · Cited by 229 · cited 1×
“If PHQ-9 score was missing, then MADRS total score was used for patients recruited by psychiatrists; remission was defined as a MADRS score 10.(44,45) If MADRS score was missing, then remission was defined as a CGI-S score 2.”
Overweight and Obesity Affect Treatment Response in Major Depression
Kloiber, S., Ising, M., Reppermund, S., Horstmann, S., Dose, T., Majer, M., Zihl, J., Pfister, H., Unschuld, P. G., Holsboer, F., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.001 · Cited by 208 · cited 8×
“In this study, the remission rate at month 2 was 29.7%; this is lower than typically reported in clinical trial settings, but is in line with the remission rate reported in more naturalistic studies, such as STAR*D. 13 The relatively low remission rate highlights the fact that achieving remission is still a major unme…”
InfluentialWoo, Y. S., Rosenblat, J. D., Kakar, R., Bahk, W.-M., & McIntyre, R. S. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.1.1 · Cited by 183
Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review
Bortolato, B., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203823 · Cited by 181 · cited 1×
“tom of MDD and a principal mediator of occupational impairment in patients in remission.(76,77) Residual cognitive symptoms”
The role of cognitive dysfunction in the symptoms and remission from depression
Gonda, X., Pompili, M., Serafini, G., Carvalho, A. F., Rihmer, Z., & Dome, P. (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0068-9 · Cited by 173 · cited 1×
“Factors explored included those previously identified in the literature and others, such as cognitive symptoms, which have been identified more recently as relevant in the course of depression and thus have been less extensively studied to date.(30,31)”
Khan, A., Khan, S. R., Shankles, E. B., & Polissar, N. L. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200211000-00003 · Cited by 162
Thase, M. E., Mahableshwarkar, A. R., Dragheim, M., Loft, H., & Vieta, E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.007 · Cited by 162
Self-citationAntidepressant-related adverse effects impacting treatment compliance: Results of a patient survey
Ashton, A. K., Jamerson, B. D., Weinstein, W., & Wagoner, C. (2005) · Current Therapeutic Research · doi:10.1016/j.curtheres.2005.04.006 · Cited by 144
Kubitz, N., Mehra, M., Potluri, R. C., Garg, N., & Cossrow, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076882 · Cited by 143
Escitalopram in the treatment of major depressive disorder: A meta-analysis
Kennedy, S. H., Andersen, H. F., & Thase, M. E. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802622726 · Cited by 140
Sexual dysfunction associated with major depressive disorder and antidepressant treatment
Clayton, A. H., El Haddad, S., Iluonakhamhe, J.-P., Ponce Martinez, C., & Schuck, A. E. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.951324 · Cited by 128
Barkow, K. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00081-2 · Cited by 119
Thase, M. E., Pritchett, Y. L., Ossanna, M. J., Swindle, R. W., Xu, J., & Detke, M. J. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a4412 · Cited by 113
Trivedi, M. H., Corey-Lisle, P. K., Guo, Z., Lennox, R. D., Pikalov, A., & Kim, E. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283277614 · Cited by 112
Gopinath, S., Katon, W. J., Russo, J. E., & Ludman, E. J. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.10.023 · Cited by 111
Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression
McGrath, P. J., Stewart, J. W., Quitkin, F. M., Chen, Y., Alpert, J. E., Nierenberg, A. A., Fava, M., Cheng, J., & Petkova, E. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1542 · Cited by 111
Major depression: the importance of clinical characteristics and treatment response to prognosis
Katon, W., Unützer, J., & Russo, J. (2010) · Depression and Anxiety · doi:10.1002/da.20613 · Cited by 107
Remission in depressed outpatients: More than just symptom resolution?
Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Boerescu, D., & Attiullah, N. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.09.004 · Cited by 98
Prediction of Recurrence in Recurrent Depression: A 5.5-Year Prospective Study
ten Doesschate, M. C., Bockting, C. L. H., Koeter, M. W. J., Schene, A. H., & DELTA Study Group (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04858blu · Cited by 98
Clinical predictors of response and remission in inpatients with depressive syndromes
Riedel, M. J., Möller, H., Obermeier, M., Adli, M., Bauer, M., Kronmüller, K., Brieger, P., Laux, G., Bender, W., Heuser, I., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.007 · Cited by 95
Mauskopf, J. A., Simon, G. E., Kalsekar, A., Nimsch, C., Dunayevich, E., & Cameron, A. (2009) · Depression and Anxiety · doi:10.1002/da.20505 · Cited by 94
Thase, M. E., Nierenberg, A. A., Vrijland, P., van Oers, H. J. J., Schutte, A.-J., & Simmons, J. H. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328330adb2 · Cited by 90
Remission onset and relapse in depression
O’Leary, D., Costello, F., Gormley, N., & Webb, M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00086-5 · Cited by 87
IsHak, W. W., Greenberg, J. M., & Cohen, R. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.048 · Cited by 78
Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms
Kurian, B. T., Greer, T. L., & Trivedi, M. H. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.53 · Cited by 73 · cited 4×
“Patient characteristics recorded included demographic information, history of MDD, characteristics of the current episode of depression, MDD management and resource use, and the presence of any other mental disorder or functional syndrome.”
InfluentialThase, M. E., Kornstein, S. G., Germain, J.-M., Jiang, Q., Guico-Pabia, C., & Ninan, P. T. (2009) · CNS Spectrums · doi:10.1017/s1092852900020125 · Cited by 66
Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression
McGrath, P. J., Stewart, J. W., Petkova, E., Quitkin, F. M., Amsterdam, J. D., Fawcett, J., Reimherr, F. W., Rosenbaum, J. F., & Beasley, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0710 · Cited by 65
Depression before and after cardiac surgery: Do all patients respond the same?
Horne, D., Kehler, D. S., Kaoukis, G., Hiebert, B. M., Garcia, E., Duhamel, T. A., & Arora, R. C. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.11.011 · Cited by 64
Quality of life: an important dimension in assessing the treatment of depression?
Kennedy, S. H., Eisfeld, B. S., & Cooke, R. G. (2001) · PubMed · Cited by 63
Zajecka, J., Kornstein, S. G., & Blier, P. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12059ah1 · Cited by 61
Katzelnick, D. J., Duffy, F. F., Chung, H., Regier, D. A., Rae, D. S., & Trivedi, M. H. (2011) · Psychiatric Services · doi:10.1176/ps.62.8.pss6208_0929 · Cited by 56
Dunlop, B. W., Li, T., Kornstein, S. G., Friedman, E. S., Rothschild, A. J., Pedersen, R., Ninan, P., Keller, M., & Trivedi, M. H. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.032 · Cited by 52
The impact of depression on workplace functioning and disability costs.
Katon, W. J. (2009) · PubMed · Cited by 48
Papakostas, G. I., & Larsen, K. G. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0149-3 · Cited by 45
Byford, S., Barrett, B. M., Despiégel, N., & Wade, A. G. (2010) · PharmacoEconomics · doi:10.2165/11537360-000000000-00000 · Cited by 43
Kim, J., Kim, S., Stewart, R., Kim, S., Yoon, J., Jung, S., Lee, M., Yim, H., & Jun, T. (2011) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1168 · Cited by 43
Yang, H., Chuzi, S., Sinicropi-Yao, L., Johnson, D., Chen, Y., Clain, A., Baer, L., McGrath, P. J., Stewart, J. W., Fava, M., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0031-3 · Cited by 42
Time to Remission for Depression with Collaborative Care Management (CCM) in Primary Care
Garrison, G. M., Angstman, K. B., O'Connor, S. S., Williams, M. D., & Lineberry, T. W. (2016) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2016.01.150128 · Cited by 41
Dennehy, E. B., Robinson, R. L., Stephenson, J. J., Faries, D., Grabner, M., Palli, S. R., Stauffer, V. L., & Marangell, L. B. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1029893 · Cited by 37
Subtypes of Depressive Episodes According to ICD-10: Prediction of Risk of Relapse and Suicide
Kessing, L. V. (2003) · Psychopathology · doi:10.1159/000075186 · Cited by 36
Rucci, P., Frank, E., Calugi, S., Miniati, M., Benvenuti, A., Wallace, M., Fagiolini, A., Maggi, L., Kupfer, D. J., & Cassano, G. B. (2011) · Depression and Anxiety · doi:10.1002/da.20894 · Cited by 33
Ejaculatory dysfunction and depression: pharmacological and psychobiological interactions
Seidman, S. N. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901509 · Cited by 31
Jiang, Q., & Ahmed, S. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-4 · Cited by 31
Wang, J. L., Patten, S. B., Currie, S., Sareen, J., & Schmitz, N. (2012) · Psychological Medicine · doi:10.1017/s0033291711001218 · Cited by 31
Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression
McGrath, P. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1542 · Cited by 31
Predictors of Major Depression Six Months After Admission for Outpatient Treatment
Weinberger, M. I., Sirey, J. A., BRUCE, M. L., Heo, M., Papademetriou, E., & Meyers, B. S. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.10.1211 · Cited by 30
Judd, L. L., Schettler, P. J., & Rush, A. J. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15111462 · Cited by 29
Nordenskjöld, A., von Knorring, L., & Engström, I. (2011) · Depression Research and Treatment · doi:10.1155/2011/470985 · Cited by 28
Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder
Fava, M., Wiltse, C. G., Walker, D. J., Brecht, S., Chen, A., & David, P. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.05.023 · Cited by 27
Hong, J., Novick, D., Montgomery, W. S., Dueñas, H., Gado, M., & Haro, J. M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75498 · Cited by 26
Self-citationDepressive Symptom Deterioration among Predominantly Hispanic Diabetes Patients in Safety Net Care
Ell, K., Katon, W. J., Lee, P.-J., Kapetanovic, S., Guterman, J. J., Xie, B., & Chou, C. (2012) · Psychosomatics · doi:10.1016/j.psym.2011.12.009 · Cited by 21
Personality Pathology Factors Predict Recurrent Major Depressive Disorder in Emerging Adults
Sheets, E. S., Duncan, L. E., Bjornsson, A. S., Craighead, L. W., & Craighead, W. E. (2013) · Journal of Clinical Psychology · doi:10.1002/jclp.22028 · Cited by 18
Jang, S., Jung, S.-W., Pae, C., Portland, K. B., Nelson, J. C., & Patkar, A. A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.023 · Cited by 18
Anxiety As a Predictor of Treatment Outcome in Children and Adolescents with Depression
Cheung, A., Mayes, T., Levitt, A., Schaffer, A., Michalak, E., Kiss, A., & Emslie, G. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0006 · Cited by 18
Angstman, K. B., Shippee, N. D., MacLaughlin, K. L., Rasmussen, N. H., Wilkinson, J. M., Williams, M. D., & Katzelnick, D. J. (2012) · Depression and Anxiety · doi:10.1002/da.22020 · Cited by 14
Examining the role of race and ethnicity in relapse rates of major depressive disorder
Trinh, N., Shyu, I., McGrath, P. J., Clain, A. J., Baer, L., D, M. F. M., & Yeung, A. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.05.004 · Cited by 7
Katzelnick, D. J., Duffy, F. F., Chung, H., et al. (2011) · Psychiatric Services · doi:10.1176/appi.ps.62.8.929 · Cited by 7
Research works printed but not linked: 3
- Sullivan JJ, Edgley K, Dehoux E. A survey of multiple sclerosis -part 1: perceived cognitive problems and compensatory strategy use. Can J Rehabil. 1990;4(2):99-105.
- Whisman MA. Depression and marital distress: findings from clinical and community studies. In: Beach SR, editor. Marital and Family Processes in Depression. Washington: American Psychological Asso- ciation; 2001:3-24.
- Zajecka J, Kornstein SG, Blier P. Residual symptoms in major depres- sive disorder: prevalence, effects, and management. J Clin Psychiatry. 2013;74(4):407-414.
Cited by
Insomnia as a predictor of mental disorders: a systematic review and meta-analysis
Hertenstein, E., Feige, B., Gmeiner, T., Kienzler, C., Spiegelhalder, K., Johann, A., Jansson-Fröjmark, M., Palagini, L., Rücker, G., Riemann, D., et al. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.10.006 · Cited by 1,201
Cognitive impairment and neurocognitive profiles in major depression: A clinical perspective
Hammar, Å., Ronold, E. H., & Rekkedal, G. Å. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.764374 · Cited by 132
“Self-reported cognitive deficits are related to both functional disability outcome and are predictors of relapse and recurrent episodes (31, 33).”
BackgroundInfluentialDale, R. M., Bryant, K. A., & Thompson, N. R. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001149 · Cited by 29
“51 of remission at month 2, but BMI did not predict relapse at month 6, although being male did.(29) As evident in some of the references already cited, there are conflicting data whether sex affects the obesity-depression connection when studying response/outcome to treatment.”
BackgroundAllott, K., Gao, C., Hetrick, S. E., Filia, K. M., Menssink, J. M., Fisher, C., Hickie, I. B., Herrman, H. E., Rickwood, D. J., Parker, A. G., et al. (2020) · BJPsych Open · doi:10.1192/bjo.2020.68 · Cited by 26
Ye, X., Xu, P., Jiao, J., Zhao, H., Jin, K., Zhang, S., Pan, F., Chen, J., Jiang, H., Hu, J., et al. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s491768 · Cited by 3
Metadata
- Authors
- Saragoussi, D., Touya, M., Haro, J. M., Jönsson, B., Knapp, M., Botrel, B., Florea, I., Loft, H., & Rive, B.
- Affiliations
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Stockholm School of Economics (SE)
- London School of Economics and Political Science (GB)
- Lundbeck (Denmark) (DK)
- Corresponding author
- Touya, Maëlys
- ORCID
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2017-08
- Volume
- Volume 13
- Pages
- 2151-2165
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC5558880
- OpenAlex
- W2742364650
- Cited by
- 63
- References
- 88
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 13 · 2020: 8 · 2019: 5 · 2018: 6 · 2017: 2
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- London School of Economics and Political Science Theses Online (London School of Economics and Political Science) (acceptedVersion)
- London School of Economics and Political Science Research Online (London School of Economics and Political Science) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, remission, relapse, antidepressant monotherapy, predictors of treatment failure, residual depressive symptoms, sexual dysfunction, depression severity, psychotherapy, sociodemographic factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.